Global Next Generation Sequencing (NGS) Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2024

  • receipt Report ID : 155495
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 136
  • list Pharmaceuticals and Healthcare

NGS is a technology in which millions and billions of DNA strands can be sequenced through massive parallelization. This technique is also known as high throughput sequencing.

Scope of the Report:

This report studies the Next Generation Sequencing (NGS) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Next Generation Sequencing (NGS) market by product type and applications/end industries.

The impact of the driving factors is expected to overcome the effect of restraints. Moreover, the utilization of cloud computing in NGS for data management and untapped emerging economies are expected to provide new market opportunities to NGS manufacturers in the near future.

North America is estimated to command the largest share of the next-generation sequencing market in 2017, followed by Europe and Asia-Pacific. Emerging markets, like China, India, and Brazil are expected to offer significant growth opportunities owing to the improving healthcare infrastructure, government funding for translational research, and rising partnerships & agreements among market players.

In addition, these countries have less-stringent regulations and data requirements as compared to developed nations; companies find regulatory policies in the Asia-Pacific region to be adaptive and business-friendly. Moreover, increasing competition in mature markets will intensify the focus on emerging markets.

The global Next Generation Sequencing (NGS) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Next Generation Sequencing (NGS).

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Illumina

Thermo Fisher Scientific

Pacific Biosciences of California

Beijing Genomics Institute

Qiagen

Roche

Agilent Technologies

Perkinelmer

Genomatix

PierianDx

Eurofins Scientific

Gatc Biotech

Oxford Nanopore Technologies

Bio-Rad Laboratories

DNASTAR

Biomatters

Partek

New England Biolabs

Myriad Genetics

Macrogen

GATC Biotech

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Consumables

Platforms

Services

Market Segment by Applications, can be divided into

Academic & Government Research Institutes

Pharmaceutical Companies

Biotechnology Companies

Hospitals & Clinics    

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Next Generation Sequencing (NGS) Market Overview

1.1 Product Overview and Scope of Next Generation Sequencing (NGS)

1.2 Classification of Next Generation Sequencing (NGS) by Types

1.2.1 Global Next Generation Sequencing (NGS) Revenue Comparison by Types (2017-2023)

1.2.2 Global Next Generation Sequencing (NGS) Revenue Market Share by Types in 2017

1.2.3 Consumables

1.2.4 Platforms

1.2.5 Services

1.3 Global Next Generation Sequencing (NGS) Market by Application

1.3.1 Global Next Generation Sequencing (NGS) Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Academic & Government Research Institutes

1.3.3 Pharmaceutical Companies

1.3.4 Biotechnology Companies

1.3.5 Hospitals & Clinics    

1.4 Global Next Generation Sequencing (NGS) Market by Regions

1.4.1 Global Next Generation Sequencing (NGS) Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Next Generation Sequencing (NGS) Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Next Generation Sequencing (NGS) Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Next Generation Sequencing (NGS) Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Next Generation Sequencing (NGS) Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Next Generation Sequencing (NGS) Status and Prospect (2013-2023)

1.5 Global Market Size of Next Generation Sequencing (NGS) (2013-2023)

2 Manufacturers Profiles

2.1 Illumina

2.1.1 Business Overview

2.1.2 Next Generation Sequencing (NGS) Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Illumina Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)

2.2 Thermo Fisher Scientific

2.2.1 Business Overview

2.2.2 Next Generation Sequencing (NGS) Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Thermo Fisher Scientific Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)

2.3 Pacific Biosciences of California

2.3.1 Business Overview

2.3.2 Next Generation Sequencing (NGS) Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Pacific Biosciences of California Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)

2.4 Beijing Genomics Institute

2.4.1 Business Overview

2.4.2 Next Generation Sequencing (NGS) Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Beijing Genomics Institute Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)

2.5 Qiagen

2.5.1 Business Overview

2.5.2 Next Generation Sequencing (NGS) Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Qiagen Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)

2.6 Roche

2.6.1 Business Overview

2.6.2 Next Generation Sequencing (NGS) Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Roche Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)

2.7 Agilent Technologies

2.7.1 Business Overview

2.7.2 Next Generation Sequencing (NGS) Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Agilent Technologies Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)

2.8 Perkinelmer

2.8.1 Business Overview

2.8.2 Next Generation Sequencing (NGS) Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Perkinelmer Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)

2.9 Genomatix

2.9.1 Business Overview

2.9.2 Next Generation Sequencing (NGS) Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Genomatix Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)

2.10 PierianDx

2.10.1 Business Overview

2.10.2 Next Generation Sequencing (NGS) Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 PierianDx Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)

2.11 Eurofins Scientific

2.11.1 Business Overview

2.11.2 Next Generation Sequencing (NGS) Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Eurofins Scientific Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)

2.12 Gatc Biotech

2.12.1 Business Overview

2.12.2 Next Generation Sequencing (NGS) Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Gatc Biotech Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)

2.13 Oxford Nanopore Technologies

2.13.1 Business Overview

2.13.2 Next Generation Sequencing (NGS) Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)

2.14 Bio-Rad Laboratories

2.14.1 Business Overview

2.14.2 Next Generation Sequencing (NGS) Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Bio-Rad Laboratories Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)

2.15 DNASTAR

2.15.1 Business Overview

2.15.2 Next Generation Sequencing (NGS) Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 DNASTAR Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)

2.16 Biomatters

2.16.1 Business Overview

2.16.2 Next Generation Sequencing (NGS) Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Biomatters Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)

2.17 Partek

2.17.1 Business Overview

2.17.2 Next Generation Sequencing (NGS) Type and Applications

2.17.2.1 Product A

2.17.2.2 Product B

2.17.3 Partek Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)

2.18 New England Biolabs

2.18.1 Business Overview

2.18.2 Next Generation Sequencing (NGS) Type and Applications

2.18.2.1 Product A

2.18.2.2 Product B

2.18.3 New England Biolabs Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)

2.19 Myriad Genetics

2.19.1 Business Overview

2.19.2 Next Generation Sequencing (NGS) Type and Applications

2.19.2.1 Product A

2.19.2.2 Product B

2.19.3 Myriad Genetics Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)

2.20 Macrogen

2.20.1 Business Overview

2.20.2 Next Generation Sequencing (NGS) Type and Applications

2.20.2.1 Product A

2.20.2.2 Product B

2.20.3 Macrogen Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)

2.21 GATC Biotech

2.21.1 Business Overview

2.2.2 Next Generation Sequencing (NGS) Type and Applications

2.21.2.1 Product A

2.21.2.2 Product B

2.21.3 GATC Biotech Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)

3 Global Next Generation Sequencing (NGS) Market Competition, by Players

3.1 Global Next Generation Sequencing (NGS) Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Next Generation Sequencing (NGS) Players Market Share

3.2.2 Top 10 Next Generation Sequencing (NGS) Players Market Share

3.3 Market Competition Trend

4 Global Next Generation Sequencing (NGS) Market Size by Regions

4.1 Global Next Generation Sequencing (NGS) Revenue and Market Share by Regions

4.2 North America Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)

4.3 Europe Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)

4.5 South America Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)

5 North America Next Generation Sequencing (NGS) Revenue by Countries

5.1 North America Next Generation Sequencing (NGS) Revenue by Countries (2013-2018)

5.2 USA Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)

5.3 Canada Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)

5.4 Mexico Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)

6 Europe Next Generation Sequencing (NGS) Revenue by Countries

6.1 Europe Next Generation Sequencing (NGS) Revenue by Countries (2013-2018)

6.2 Germany Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)

6.3 UK Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)

6.4 France Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)

6.5 Russia Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)

6.6 Italy Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Next Generation Sequencing (NGS) Revenue by Countries

7.1 Asia-Pacific Next Generation Sequencing (NGS) Revenue by Countries (2013-2018)

7.2 China Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)

7.3 Japan Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)

7.4 Korea Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)

7.5 India Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)

8 South America Next Generation Sequencing (NGS) Revenue by Countries

8.1 South America Next Generation Sequencing (NGS) Revenue by Countries (2013-2018)

8.2 Brazil Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)

8.3 Argentina Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)

8.4 Colombia Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Next Generation Sequencing (NGS) by Countries

9.1 Middle East and Africa Next Generation Sequencing (NGS) Revenue by Countries (2013-2018)

9.2 Saudi Arabia Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)

9.3 UAE Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)

9.4 Egypt Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)

9.5 Nigeria Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)

9.6 South Africa Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)

10 Global Next Generation Sequencing (NGS) Market Segment by Type

10.1 Global Next Generation Sequencing (NGS) Revenue and Market Share by Type (2013-2018)

10.2 Global Next Generation Sequencing (NGS) Market Forecast by Type (2018-2023)

10.3 Consumables Revenue Growth Rate (2013-2023)

10.4 Platforms Revenue Growth Rate (2013-2023)

10.5 Services Revenue Growth Rate (2013-2023)

11 Global Next Generation Sequencing (NGS) Market Segment by Application

11.1 Global Next Generation Sequencing (NGS) Revenue Market Share by Application (2013-2018)

11.2 Next Generation Sequencing (NGS) Market Forecast by Application (2018-2023)

11.3 Academic & Government Research Institutes Revenue Growth (2013-2018)

11.4 Pharmaceutical Companies Revenue Growth (2013-2018)

11.5 Biotechnology Companies Revenue Growth (2013-2018)

11.6 Hospitals & Clinics     Revenue Growth (2013-2018)

12 Global Next Generation Sequencing (NGS) Market Size Forecast (2018-2023)

12.1 Global Next Generation Sequencing (NGS) Market Size Forecast (2018-2023)

12.2 Global Next Generation Sequencing (NGS) Market Forecast by Regions (2018-2023)

12.3 North America Next Generation Sequencing (NGS) Revenue Market Forecast (2018-2023)

12.4 Europe Next Generation Sequencing (NGS) Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Next Generation Sequencing (NGS) Revenue Market Forecast (2018-2023)

12.6 South America Next Generation Sequencing (NGS) Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Next Generation Sequencing (NGS) Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Next Generation Sequencing (NGS) Picture

Table Product Specifications of Next Generation Sequencing (NGS)

Table Global Next Generation Sequencing (NGS) and Revenue (

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery